Skip to main content

A closer look at heart disease risk

Coronary artery calcium scans can help identify dangerous plaque buildup.

Predicting heart disease has never been an exact science. Some factors — such as high blood pressure and high cholesterol levels (especially LDL or "bad" cholesterol), diabetes, and smoking — can help predict future risk. But the presence of atherosclerosis, the disease underlying most heart attacks, is not always easy to spot. That's where a coronary artery calcium (CAC) scan may come in handy. It measures the amount of calcium in the heart's arteries, high levels of which are associated with heart disease.
"The CAC results can help identify a person's possible risk for heart attack or stroke, even if that person doesn't have the obvious risk factors or symptoms," says Dr. Jorge Plutzky, director of preventive cardiology at Harvard-affiliated Brigham and Women's Hospital. "It can be a way for some people to get the necessary treatment early and hopefully head off a serious cardiac event."

How the test works

A CAC scan uses a special computed tomography (CT) scanner, such as an electron beam CT or a multidetector CT machine. You lie on your back with electrodes placed on your chest to monitor your heart rate. The scanner then takes several pictures of your heart over the course of 20 to 30 seconds.
Too much plaque buildup in the heart's arteries can restrict blood flow to the heart muscle and increase your chance of a heart attack. It's also associated with a higher stroke risk.
For unknown reasons, that plaque sometimes calcifies, and the calcium shows up on the scan as small white specks. "The calcification process mainly identifies that atherosclerosis is present, but does not necessarily pinpoint areas that will rupture and cause a heart attack," says Dr. Plutzky.
The amount of calcification is scored on a scale from zero to 400 and higher. The lower the score, the less calcium, and in general, the less likelihood of a heart attack or stroke (see "CAC scores").

CAC scores

SCORE
PRESENCE OF PLAQUE
0
No evidence of plaque. There is less than a 5% chance of having heart disease over a 10-year period. Heart attack risk is very low.
1 to 10
A small amount of plaque is present. There is less than a 10% chance of having heart disease over a 10-year period. Heart attack risk is low.
11 to 100
Plaque is present, which means a person has mild heart disease. Heart attack risk is moderate.
101 to 400
A moderate amount of plaque may be blocking an artery. Heart attack risk is moderate to high.
401 and higher
There is a large amount of plaque and a 90% and higher chance it is blocking an artery. Heart attack risk is high.

Other potential benefits

Cardiologists continue to wrestle with how best to integrate CAC scans into diagnosis and treatment. For many people whose risk is obvious — like those who've already had a heart attack or stent placement — the CAC results won't make any difference in medical decisions, given the obvious need for aggressive treatments.
However, the scan is especially helpful for people who fall into a gray area. For instance, a man may have strong health numbers, like good blood pressure and cholesterol levels, but also a family history of heart disease that includes a father, brother, or uncle who had a heart attack in his early 50s.
A CAC scan also can help someone who's at intermediate risk — for example, a 60-year-old man with average cholesterol levels, borderline blood pressure, and a history of smoking. "His CAC score can help determine if he needs intervention with treatments like cholesterol-lowering statins," says Dr. Plutzky.
Insurance coverage of a CAC scan can vary, but most out-of-pocket costs range from $100 to $200. The scan is usually repeated every five to 10 years.
A CAC doesn't replace the value of the more common stress test, which can indicate significant coronary blockages. But for some men, a CAC scan can provide extra guidance to make smarter decisions about their heart health.
"Doctors can only test for risk factors that are known and established," says Dr. Plutzky. "When a patient's cardiovascular risk is not clear, a CAC scan is another tool to assess what may be going on."
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.https://www.health.harvard.edu/heart-health/a-closer-look-at-heart-disease-risk

Comments

Popular posts from this blog

4th Global Summit on Heart Diseases March 15-16, 2019 Singapore

About Conference After the splendid success of “ 2 nd  World Heart Congress ” held at Tokyo, Japan during May 14-16, 2018 we proudly announce the " 4 th  Global Summit on Heart Diseases " which will be held during  March 15-16, 2019  at  Singapore . Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations) Get participation certificate from Heart Diseases Summit 2018 Organising Committee Members You can make contacts with eminent keynote speakers and research professionals for your career growth. Get 5 star hospitality at the conference venue  B 2 B Meeting with the Companies Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations) Full Conference Kit with Conference Souvenir and Final Program (e-copies) Abstracts will be published in the conference souvenir and respective International journals Each Abstract will receive unique (DOI) Number provided by Cross

Classification of Cardiovascular Drugs

Classification of Cardiovascular Drugs The hashtag # Cardiovascular_Drugs Cardiovascular agents are medicines that are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. Discuss on Various Classification of Cardiovascular Drugs and their Novel Developments at the Heart Diseases Summit 2020 on april 20-21,2020 Discussion on various topics on Heart Diseases Carried out at  https://heartdiseases.conferenceseries.com/asiapacific/ For more details  Contact  Samanta Grace  Program Manager  heartdiseases@asiameets.com website :  https://heartdiseases.conferenceseries.com/asiapacific/ hashtag # cardiovascular hashtag # cardiovascular hashtag # cardiology hashtag # diabetes hashtag # cancer hashtag # cardiovascular_disease hashtag # heart_disease hashtag # heart_diseases hashtag #
                                                              Global Summit on Heart Diseases April 20-21, 2020 | Kyoto, Japan Theme: Accelerated action to prevent the Cardiovascular diseases